Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 5 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Neoplasms 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Glioma 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Brain Neoplasms 3 Astrocytoma 3 Sarcoma 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Lung Neoplasms 2 Carcinoma, Squamous Cell 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Skin Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Rhabdomyosarcoma 1 Recurrence 1 Radiation Injuries 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Postoperative Complications 1 Pilonidal Sinus 1

Interventions

Cisplatin 22 Magnetic Resonance Spectroscopy 15 Specimen Handling 13 Platinum 12 Radiotherapy, Intensity-Modulated 11 1,2-diaminocyclohexaneplatinum II citrate 11 Radiotherapy 10 Radiation 10 Carboplatin 9 Surveys and Questionnaires 5 Biopsy 5 pembrolizumab 4 Taxes 4 Paclitaxel 4 Nivolumab 4 Docetaxel 4 Chemoradiotherapy 4 Cetuximab 4 Observation 3 Fluorodeoxyglucose F18 3 (225)Ac-DOTA-c(RGDyK) 3 durvalumab 2 X-Rays 2 Watchful Waiting 2 Standard of Care 2 Radiotherapy, Image-Guided 2 Interviews as Topic 2 Immunoglobulin G 2 Fluorouracil 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Oropharyngeal Neoplasms × Surgical Procedures, Operative × 90 days × Clear all

NCT06702033 2026-05-15

MINT-2

Washington University School of Medicine

Phase 2 Recruiting

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡